Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Uhrberg

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|October 11, 2023
Corrigendum: Efficient <i>in vitro</i> generation of IL-22-secreting ILC3 from CD34+ hematopoietic progenitors in a human mesenchymal stem cell nicheSabrina B Bennstein, Sandra Weinhold, Özer Degistirici, et al.
Blood|August 29, 2014
KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapseFlorian Babor, Angela R Manser, Johannes C Fischer, et al.
BMC Research Notes|August 5, 2010
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cellsRui Neves, Christina Scheel, Sandra Weinhold, et al.
Cancer Immunology, Immunotherapy : CII|August 16, 2021
CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALLSarah B Reusing, Dan A Vallera, Angela R Manser, et al.
Emerging Microbes & Infections|May 28, 2024
SARS-CoV-2 infection induces adaptive NK cell responses by spike protein-mediated induction of HLA-E expressionMohammad Zahidul Hasan, Maren Claus, Nadine Krüger, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2021
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALLSarah B Reusing, Dan A Vallera, Angela R Manser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Conservation and variation in human and common chimpanzee CD94 and NKG2 genesBenny P Shum, Laura R Flodin, David G Muir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptorJohannes C Fischer, Hellmut Ottinger, Stanislav Ferencik, et al.
British Journal of Haematology|November 4, 2015
Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemiaSarah B Reusing, Angela R Manser, Jürgen Enczmann, et al.
Bone Marrow Transplantation|March 4, 2021
HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantationSarah B Reusing, Angela R Manser, Stefanie Groeneveld-Krentz, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|October 11, 2023
Corrigendum: Efficient <i>in vitro</i> generation of IL-22-secreting ILC3 from CD34+ hematopoietic progenitors in a human mesenchymal stem cell nicheSabrina B Bennstein, Sandra Weinhold, Özer Degistirici, et al.
Blood|August 29, 2014
KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapseFlorian Babor, Angela R Manser, Johannes C Fischer, et al.
BMC Research Notes|August 5, 2010
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cellsRui Neves, Christina Scheel, Sandra Weinhold, et al.
Cancer Immunology, Immunotherapy : CII|August 16, 2021
CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALLSarah B Reusing, Dan A Vallera, Angela R Manser, et al.
Emerging Microbes & Infections|May 28, 2024
SARS-CoV-2 infection induces adaptive NK cell responses by spike protein-mediated induction of HLA-E expressionMohammad Zahidul Hasan, Maren Claus, Nadine Krüger, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2021
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALLSarah B Reusing, Dan A Vallera, Angela R Manser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Conservation and variation in human and common chimpanzee CD94 and NKG2 genesBenny P Shum, Laura R Flodin, David G Muir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptorJohannes C Fischer, Hellmut Ottinger, Stanislav Ferencik, et al.
British Journal of Haematology|November 4, 2015
Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemiaSarah B Reusing, Angela R Manser, Jürgen Enczmann, et al.
Bone Marrow Transplantation|March 4, 2021
HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantationSarah B Reusing, Angela R Manser, Stefanie Groeneveld-Krentz, et al.
Pageof 8